Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Hort

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|May 18, 2019
Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive DeficitsJakub Hort, Martin Vališ, Kamil Kuča, et al.
Journal of Neuroinflammation|May 24, 2019
Antibiotics, gut microbiota, and Alzheimer's diseaseFrancesco Angelucci, Katerina Cechova, Jana Amlerova, et al.
Neuro Endocrinology Letters|February 20, 2008
Long lasting recurrent familiar transient global amnesia after betablocker treatment withdrawal: case reportMartin Vyhnálek, Martin Bojar, Jaroslav Jerabek, et al.
CNS Neuroscience & Therapeutics|November 8, 2018
Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implicationsFrancesco Angelucci, Kateřina Čechová, Richard Průša, et al.
Cyberpsychology, Behavior and Social Networking|September 17, 2024
Virtual Reality Tennis Training: Performance Gains Derived from User CharacteristicsRoss Andel, Timothy McMahan, Thomas D Parsons, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 28, 2016
Costs of dementia in the Czech RepublicIva Holmerová, Jakub Hort, Robert Rusina, et al.
Clinical Interventions in Aging|September 9, 2015
Alzheimer's disease and language impairments: social intervention and medical treatmentBlanka Klimova, Petra Maresova, Martin Valis, et al.
Journal of Cellular and Molecular Medicine|February 22, 2024
Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degenerationFrancesco Angelucci, Katerina Veverova, Alžbeta Katonová, et al.
ACS Omega|October 9, 2023
Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease SeverityFrancesco Angelucci, Katerina Veverova, Alžbeta Katonová, et al.
Current Neuropharmacology|April 20, 2026
Subjects Affected by Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA) Elevated Brain-Derived Neurotrophic Factor (BDNF) Serum LevelsFrancesco Angelucci, Zuzana Nedelska, Daniela Imal, et al.
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|May 18, 2019
Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive DeficitsJakub Hort, Martin Vališ, Kamil Kuča, et al.
Journal of Neuroinflammation|May 24, 2019
Antibiotics, gut microbiota, and Alzheimer's diseaseFrancesco Angelucci, Katerina Cechova, Jana Amlerova, et al.
Neuro Endocrinology Letters|February 20, 2008
Long lasting recurrent familiar transient global amnesia after betablocker treatment withdrawal: case reportMartin Vyhnálek, Martin Bojar, Jaroslav Jerabek, et al.
CNS Neuroscience & Therapeutics|November 8, 2018
Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implicationsFrancesco Angelucci, Kateřina Čechová, Richard Průša, et al.
Cyberpsychology, Behavior and Social Networking|September 17, 2024
Virtual Reality Tennis Training: Performance Gains Derived from User CharacteristicsRoss Andel, Timothy McMahan, Thomas D Parsons, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 28, 2016
Costs of dementia in the Czech RepublicIva Holmerová, Jakub Hort, Robert Rusina, et al.
Clinical Interventions in Aging|September 9, 2015
Alzheimer's disease and language impairments: social intervention and medical treatmentBlanka Klimova, Petra Maresova, Martin Valis, et al.
Journal of Cellular and Molecular Medicine|February 22, 2024
Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degenerationFrancesco Angelucci, Katerina Veverova, Alžbeta Katonová, et al.
ACS Omega|October 9, 2023
Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease SeverityFrancesco Angelucci, Katerina Veverova, Alžbeta Katonová, et al.
Current Neuropharmacology|April 20, 2026
Subjects Affected by Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA) Elevated Brain-Derived Neurotrophic Factor (BDNF) Serum LevelsFrancesco Angelucci, Zuzana Nedelska, Daniela Imal, et al.
Pageof 19